Autophagy and Obesity-Related Reproductive Dysfunction
1Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiaotong University, 160 Pujian Road, Shanghai, 200127, China. taotaozhen@hotmail.com.
Advances in Experimental Medicine and Biology
|July 17, 2020
Summary
Polycystic Ovary Syndrome (PCOS), a common reproductive disease, involves ovarian changes linked to autophagy. Further research is needed to understand autophagy's role in PCOS development and progression.
Area of Science:
- Reproductive Endocrinology
- Cellular Biology
- Metabolic Disorders
Background:
- Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine and metabolic disorder in women of reproductive age.
- PCOS is characterized by hyperandrogenism, hyperinsulinemia, and ovarian dysfunction, including morphological and functional changes.
- Autophagy, a cellular degradation process, plays a role in ovarian physiology and granulosa cell survival.
Purpose of the Study:
- To review the current research on the relationship between autophagy and Polycystic Ovary Syndrome (PCOS).
- To explore the involvement of autophagy in the pathogenesis of PCOS.
Main Methods:
- Literature review of recent studies on autophagy and PCOS.
- Analysis of the role of autophagy in ovarian function and granulosa cell survival.
Main Results:
- Autophagy is implicated in maintaining ovarian physiological function and granulosa cell survival.
- Evidence suggests a connection between altered autophagy and the development of PCOS.
Conclusions:
- Autophagy is involved in ovarian function and may play a role in PCOS.
- The precise mechanisms by which autophagy influences PCOS occurrence and progression require further investigation.
Related Concept Videos
01:36Delivery Pathways to the Lysosome
8.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.6K
01:24Obesity
1.0K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.0K
01:27Autophagy
5.5K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
104
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
104
01:18Autophagic Cell Death
4.1K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.1K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
147
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
147